492 results on '"Schneider, Rebekka K"'
Search Results
2. Endothelial LATS2 is a suppressor of bone marrow fibrosis
3. Adamts12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts
4. Author Correction: Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
5. Periodontal ligament and alveolar bone remodeling during long orthodontic tooth movement analyzed by a novel user-independent 3D-methodology
6. Inflammation drives pressure on TP53 mutant clones in myeloproliferative neoplasms
7. Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation
8. Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow niche
9. Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms
10. Expansion-enhanced super-resolution radial fluctuations enable nanoscale molecular profiling of pathology specimens
11. Biological drivers of clinical phenotype in myelofibrosis
12. Met-Signaling Controls Dendritic Cell Migration in Skin by Regulating Podosome Formation and Function
13. Sublethal necroptosis signaling promotes inflammation and liver cancer
14. Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner
15. Adult human kidney organoids originate from CD24+ cells and represent an advanced model for adult polycystic kidney disease
16. Spatial multi-omic map of human myocardial infarction
17. Single-cell analysis of cultured bone marrow stromal cells reveals high similarity to fibroblasts in situ
18. Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansion
19. Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
20. Mapping the cardiac vascular niche in heart failure
21. Detection of cell markers from single cell RNA-seq with sc2marker
22. From cell to cell: Identification of actionable targets in bone marrow fibrosis using single-cell technologies
23. Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
24. Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN
25. Malignant Transformation Involving CXXC4 Mutations Identified in a Leukemic Progression Model of Severe Congenital Neutropenia
26. Decoding myofibroblast origins in human kidney fibrosis
27. Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm
28. Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation
29. Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation
30. The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis
31. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis
32. Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome
33. Mesenchymal Stem Cells in Fibrotic Disease
34. Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target
35. Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease
36. Physiologic Expression of Sf3b1K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation
37. Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML
38. “ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
39. SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice
40. Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
41. Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
42. Data from Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
43. Supplementary Table S1 from Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
44. Supplementary Figure S1 from Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
45. Supplementary Methods, Figure Legends, Table Legends from Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
46. Protocol to analyze bioenergetics in single human induced-pluripotent-stem-cell-derived kidney organoids using Seahorse XF96
47. Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide
48. Perivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis
49. Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms
50. Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.